Christelle Orlando

Christelle Orlando

Auto-generated profile, based on publicly available information

Christelle Orlando

Department of Hematology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2019 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
ECElizabeth M. Van Cott
Elizabeth M. Van Cott
COChristelle Orlando
Christelle Orlando
GMGary Moore
Gary Moore
PCPeter C. Cooper
Peter C. Cooper
PMPiet Meijer
Piet Meijer
TIThe Subcommittee On Plasma Coagulation Inhibitors
The Subcommittee On Plasma Coagulation Inhibitors

1 June 2015 in Thrombosis Research
Verified
Journal Article
Closed access
COChristelle Orlando
Christelle Orlando
OHOlivier Heylen
Olivier Heylen
WLWilly Lissens
Willy Lissens
KJKristin Jochmans
Kristin Jochmans

11 April 2019 in Haematologica
Verified
Journal Article
Open access
PDF file
BMBelén de la Morena-Barrio
Belén de la Morena-Barrio
COChristelle Orlando
Christelle Orlando
MMMaría Eugenia de la Morena-Barrio
María Eugenia de la Morena-Barrio
VVVicente Vicente
Vicente Vicente
KJKristin Jochmans
Kristin Jochmans
JCJavier Corral
Javier Corral
Pediatric thromboembolism (≤18 years) is very rare (0.07-0.14/10,000/year) but may be more prevalent in children with severe thrombophilia (protein C, protein S or antithrombin deficiency). The aim of this study was to define the prevalence and clinical characteristics of pediatric thrombosis in subjects with inherited antithrombin deficiency. Our observational retrospective multicentric study from two countries recruited 968 patients of any age from 441 unrelated families with genetically, biochemically and functionally characterized antithrombin deficiency. Seventy-three subjects (7.5%) developed thrombosis before 19 years of age. Two high risk periods for thrombosis were identified: adolescence (12-18 years, n=49) with thrombus localization (lower limb, deep venous thrombosis or pulmonary embolism) and triggering factors common to adults (oral contraceptives, surgery or pregnancy); and neonatal period (<30 days, n=15) with idiopathic thrombosis at unusual sites. The clinical evaluation of pediatric thrombosis in subjects with antithrombin deficiency revealed: i) a high prevalence of cerebral sinovenous thrombosis (n=13, 17.8%), mainly at young age (8 neonates and 4 children <6 years); ii) severe outcome with fatality in 6 cases (3 neonates, two of them homozygous for p.Leu131Phe). The majority of subjects (76.7%) carried quantitative type I deficiency. This retrospective analysis of the so far largest cohort of subjects with inherited antithrombin deficiency provides strong evidence for an increased risk of pediatric thrombosis associated with this thrombophilia (300-fold compared with the general population: 0.41%/year vs 0.0014%/year, respectively). Our results support testing for antithrombin deficiency in children of affected families, particularly in case of type I deficiency.

23 February 2022 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
BMBelén de la Morena-Barrio
Belén de la Morena-Barrio
COChristelle Orlando
Christelle Orlando
ASAlba Sanchis-Juan
Alba Sanchis-Juan
JGJuan L. García
Juan L. García
JPJosé Padilla
José Padilla
JCJavier Corral
Javier Corral

19 March 2021 in European Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Maria Eugenia de la Morena-BarrioMaria Eugenia de la Morena-Barrio
Maria Eugenia de la Morena-Barrio
CBCarlos Bravo-Perez
Carlos Bravo-Perez
BMBelen de la Morena‐Barrio
Belen de la Morena‐Barrio
COChristelle Orlando
Christelle Orlando
RCRosa Cifuentes
Rosa Cifuentes
MLMaría Luisa Lozano
María Luisa Lozano
Click on the article title to read more.

3 October 2020 in Acta Clinica Belgica
Verified
Journal Article
Closed access
TVThomas Vanassche
Thomas Vanassche
COChristelle Orlando
Christelle Orlando
KVKristel Vandenbosch
Kristel Vandenbosch
AGAlain Gadisseur
Alain Gadisseur
CHCédric Hermans
Cédric Hermans
COCécile Oury
Cécile Oury
COVID-19 predisposes patients to thrombotic disease. The aim of this guidance document is to provide Belgian health-care workers with recommendations on anticoagulation management in COVID-19 posit...